Skip to main content
Ch. 15 - Gene Mutation, DNA Repair, and Transposition
Chapter 15, Problem 23

In a bacterial culture in which all cells are unable to synthesize leucine (leu⁻), a potent mutagen is added, and the cells are allowed to undergo one round of replication. At that point, samples are taken, a series of dilutions are made, and the cells are plated on either minimal medium or minimal medium containing leucine. The first culture condition (minimal medium) allows the growth of only leu⁺ cells, while the second culture condition (minimal medium with leucine added) allows growth of all cells. The results of the experiment are as follows: Culture Condition Dilution Colonies Minimal medium 10⁻¹ 18 Minimal medium + leucine 10⁻⁷ 9 What is the rate of mutation at the locus associated with leucine biosynthesis?

Verified Solution

Video duration:
1m
This video solution was recommended by our tutors as helpful for the problem above.
Was this helpful?

Key Concepts

Here are the essential concepts you must grasp in order to answer the question correctly.

Mutation Rate

The mutation rate refers to the frequency at which new mutations occur in a given gene or locus over a specific period or number of cell divisions. It is typically expressed as the number of mutations per cell division or per generation. In this context, understanding the mutation rate is crucial for determining how often leu⁻ cells can revert to leu⁺ cells, which are capable of synthesizing leucine.
Recommended video:
Guided course
10:48
Mutations and Phenotypes

Selective Media

Selective media are types of growth media that allow for the growth of certain organisms while inhibiting others. In this experiment, minimal medium only supports the growth of leu⁺ cells, while minimal medium with leucine allows all cells to grow. This distinction is essential for analyzing the results, as it helps differentiate between the original leu⁻ cells and those that have mutated to leu⁺.
Recommended video:
Guided course
05:58
Natural Selection

Dilution Plating

Dilution plating is a technique used to estimate the concentration of viable microorganisms in a sample. By diluting the original culture and plating it on selective media, researchers can count the number of colonies that grow. This method is important for calculating the mutation rate, as it allows for the quantification of leu⁺ colonies in relation to the total number of cells present in the original culture.
Recommended video:
Guided course
09:06
Meiosis Steps
Related Practice
Textbook Question
Many of the gene products involved in DNA synthesis were initially defined by studying mutant E. coli strains that could not synthesize DNA. The dnaE gene encodes the α subunit of DNA polymerase III. What effect is expected from a mutation in this gene? How could the mutant strain be maintained?
258
views
Textbook Question
Many of the gene products involved in DNA synthesis were initially defined by studying mutant E. coli strains that could not synthesize DNA. The dnaQ gene encodes the ε subunit of DNA polymerase. What effect is expected from a mutation in this gene?
274
views
Textbook Question
A fellow student considers the issues in Problem 22 and argues that there is a more straightforward, nongenetic experiment that could differentiate between the two types of mutations. The experiment requires no fancy genetics and would allow you to easily assay the products of the other SOS genes. Propose such an experiment.
212
views
Textbook Question

In 2010, a U.S. District Judge ruled to invalidate Myriad Genetics' patents on the BRCA1 and BRCA2 genes. Judge Sweet noted that since the genes are part of the natural world, they are not patentable. Myriad Genetics also holds patents on the development of a direct-to-consumer test for the BRCA1 and BRCA2 genes.

Would you agree with the ruling to invalidate the patenting of the BRCA1 and BRCA2 genes? If you were asked to judge the patenting of the direct-to-consumer test for the BRCA1 and BRCA2 genes, how would you rule?

224
views
Textbook Question

In 2010, a U.S. District Judge ruled to invalidate Myriad Genetics' patents on the BRCA1 and BRCA2 genes. Judge Sweet noted that since the genes are part of the natural world, they are not patentable. Myriad Genetics also holds patents on the development of a direct-to-consumer test for the BRCA1 and BRCA2 genes.

J. Craig Venter has filed a patent application for his 'first-ever human-made life form.' This patent is designed to cover the genome of M. genitalium. Would your ruling for Venter's 'organism' be different from the judge's ruling on patenting of the BRCA1 and BRCA2 genes?

208
views
Textbook Question
Presented here are hypothetical findings from studies of heterokaryons formed from seven human xeroderma pigmentosum cell strains: XP1 XP2 XP3 XP4 XP5 XP6 XP7 XP1 - XP2 - - XP3 - - - XP4 + + + - XP5 + + + + - XP6 + + + + - - XP7 + + + + - - - Note: + = complementation; - = no complementation These data are measurements of the occurrence or nonoccurrence of unscheduled DNA synthesis in the fused heterokaryon. None of the strains alone shows any unscheduled DNA synthesis. Which strains fall into the same complementation groups? How many different groups are revealed based on these data? What can we conclude about the genetic basis of XP from these data?
381
views